Renaissance Technologies - TONIX PHARMACEUTICALS HLDG C ownership

TONIX PHARMACEUTICALS HLDG C's ticker is and the CUSIP is 890260862. A total of 48 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of TONIX PHARMACEUTICALS HLDG C
ValueSharesWeighting
Q1 2023$723
+53.5%
1,222,424
+1.2%
0.00%0.0%
Q4 2022$471
-100.0%
1,208,224
-35.7%
0.00%0.0%
Q3 2022$1,004,000
-1.2%
1,879,137
+192.2%
0.00%0.0%
Q2 2022$1,016,000643,1240.00%
Other shareholders
TONIX PHARMACEUTICALS HLDG C shareholders Q3 2022
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 1,100,419$650,4580.10%
Virtu Financial LLC 58,883$350.00%
HANTZ FINANCIAL SERVICES, INC. 85,690$510.00%
Renaissance Technologies 1,222,424$7230.00%
Simplicity Solutions, LLC 36,670$21,6760.00%
Federation des caisses Desjardins du Quebec 158$930.00%
RAYMOND JAMES & ASSOCIATES 266,188$157,3440.00%
COMMONWEALTH EQUITY SERVICES, LLC 38,359$220.00%
Advisory Services Network, LLC 1$10.00%
Focused Wealth Management, Inc 222$1310.00%
View complete list of TONIX PHARMACEUTICALS HLDG C shareholders